Related Experiment Video
Updated: Apr 27, 2026

09:43
Efficient Generation Human Induced Pluripotent Stem Cells from Human Somatic Cells with Sendai-virus
Published on: April 23, 2014
22.2K
Human induced pluripotent stem cells: now open to discovery
1Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cell Stem Cell
|July 5, 2014
Summary
Human induced pluripotent stem cells (iPSCs) offer disease research potential. A new study utilized patient-derived iPSCs with genetic risk variants to uncover novel disease pathology insights.
Area of Science:
- Stem cell biology
- Genetics
- Disease pathology
Background:
- Human induced pluripotent stem cells (iPSCs) hold promise for disease research.
- Their potential for uncovering disease mechanisms remains largely untapped.
- Investigating genetic risk variants is crucial for understanding disease etiology.
Purpose of the Study:
- To leverage patient-derived iPSCs harboring genetic risk variants.
- To gain novel insights into the underlying pathology of diseases.
- To advance the application of iPSCs in biomedical research.
Main Methods:
- Generation of iPSCs from patients with specific genetic risk variants.
- Analysis of cellular phenotypes and molecular mechanisms in iPSC models.
- Comparison of patient-derived iPSCs with control lines.
Main Results:
- Identification of disease-specific cellular and molecular alterations in iPSCs.
- Discovery of novel pathways involved in disease pathogenesis.
- Demonstration of iPSCs as a viable model for studying genetic disease.
Conclusions:
- Patient-derived iPSCs carrying genetic risk variants are valuable tools for disease research.
- This approach can reveal previously unknown aspects of disease pathology.
- Further application of iPSCs can accelerate the discovery of disease mechanisms and potential therapies.
Related Concept Videos
Induced Pluripotent Stem Cells
22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Induced Pluripotent Stem Cells
4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.8K
Induced Pluripotent Stem Cells
3.4K
3.4K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

